| 
 | 
| Characteristic | OS | PFS | 
| 95% CI |  | value | 95% CI |  | value | 
| 
 | 
| Age (years) |  |  |  |  |  |  | 
| <60/≥60 | 24.681-37.319 vs. 31.774-48.226 | 5.360 | 0.02 | 13.920-34.080 vs. 14.944-45.056 | 3.761 | 0.05 | 
| Gender |  |  |  |  |  |  | 
| Male/female | 30.714-26.587 vs. 26.587-45.413 | 0.081 | 0.78 | 16.493-31.507 vs. 13.258-48.742 | 1.077 | 0.30 | 
| Ethnicity |  |  |  |  |  |  | 
| Han/Kazakh | 25.206-46.794 vs. 33.988-46.012 | 0.164 | 0.67 | 16.037-31.963 vs. 19.773-42.227 | 1.136 | 0.29 | 
| Tumor location |  |  |  |  |  |  | 
| Upper/middle/lower | 20.088-75.912 vs. 34.733-45.267 vs. 25.607 vs. 40.393 | 2.183 | 0.34 | 0-99.530 vs. 11.042-40.958 vs. 10.175 vs. 37.825 | 1.063 | 0.59 | 
| Tumor size |  |  |  |  |  |  | 
| <3 cm/≥3 cm | 35.063-48.937 vs. 24.025-41.975 | 4.267 | 0.04 | 33.675-46.325 vs. 15.498-24.502 | 3.908 | 0.04 | 
| Degree of differentiation |  |  |  |  |  |  | 
| Poor/moderate/well | 12.573-43.427 vs. 34.313-45.687 vs. 28.959-51.041 | 6.521 | 0.04 | 15.678-20.322 vs. 15.539-32.641 vs. 20.402-99.598 | 9.072 | 0.01 | 
| Lymph node metastasis |  |  |  |  |  |  | 
| Negative/positive | 33.142-48.858 vs. 15.820-24.180 | 8.730 | 0.003 | 29.674-42.326 vs. 6.921-17.079 | 11.888 | 0.001 | 
| Invasive depth |  |  |  |  |  |  | 
| Mucosa/muscularis/full thickness | 0-85.4 vs. 35.377-44.623 vs. 28.313-43.687 | 0.487 | 0.78 | 0-39.4 vs. 17.492-42.508 vs. 16.086-31.914 | 2.109 | 0.35 | 
| AJCC stage |  |  |  |  |  |  | 
| I/II/III/IV | 6.073-65.927 vs. 33.591-48.409 vs. 17.713-22.287 vs. 5.721-54.279 | 7.261 | 0.06 | 0-46.624 vs. 28.118-43.882 vs. 12.85-21.15 vs. 8.911-15.089 | 9.911 | 0.02 | 
| Vascular invasion |  |  |  |  |  |  | 
| Negative/positive | 30.609-41.391 vs. 31.516-48.484 | 0.274 | 0.60 | 15.312-38.688 vs. 11.752-36.248 | 0.634 | 0.43 | 
| Nerve invasion |  |  |  |  |  |  | 
| Negative/positive | 34.737-45.263 vs. 6.270-41.730 | 5.197 | 0.02 | 19.232-40.768 vs. 0-32.479 | 7.272 | 0.007 | 
| Hematogenous metastasis |  |  |  |  |  |  | 
| Negative/positive | 29.139-42.861 vs. 31.769-40.231 | 0.547 | 0.46 | 19.595-40.405 vs. 3.368-36.632 | 3.407 | 0.07 | 
| MACC1 expression |  |  |  |  |  |  | 
| Negative/positive | 27.368-38.632 vs. 25.557-58.443 | 6.985 | 0.008 | 13.556-34.444 vs. 17.052-42.948 | 1.921 | 0.17 | 
| c-Met expression |  |  |  |  |  |  | 
| Negative/positive | 29.822-43.453 vs. 49.128-65.143 | 21.173 | <0.001 | 12.271-23.729 vs. 28.620-47.740 | 8.991 | 0.003 | 
| Cyclin D1 expression |  |  |  |  |  |  | 
| Negative/positive | 27.638-44.362 vs. 31.777-40.223 | 0.111 | 0.74 | 21.643-48.357 vs. 18.494-29.506 | 0.302 | 0.58 | 
| 
 |